RIO DE JANEIRO, BRAZIL – The announcement was made by David Zigdon, CEO of the Galilee Research Institute (Migal), located in Galilee, Israel. Zigdon held a press conference on Thursday, February 27th, along with his team, to announce progress in the research.
According to the scientist, the team has been working tirelessly on the development of a vaccine against the coronavirus. Preliminary tests in birds have proved its efficacy and the team is now looking for adaptations that will enable immunization in humans.
“We are working to get an effective vaccine [for humans] against COVID-19 in eight to ten weeks, and to move to testing in humans in 90 days,” Zigdon said. The researcher added that both the vaccine for birds and for humans must be administered orally.
The team working on the project is specialized in biotechnology, environment, and agriculture. The initiative earned public praise from Israeli Science and Technology Minister Ofir Akunis. “I hope and pray for progress soon,” he said.
The news was shared by the Israeli institute on its Facebook page.
Source: Diario Online
This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error
Israel Election 2026
- Israel Pick Sends Netanyahu Exit Odds to 68%
- Israel Count: Netanyahu 53, Eisenkot 48
- No Israeli Party Has Ever Won 61 Seats
- Netanyahu Faces Bribery Charge, No Verdict
Read More from The Rio Times